| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults
|
Vasu, Sumithira
|
|
|
6 |
4 |
p. 1342-1349
|
article
|
| 2 |
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
|
Gerds, Aaron T.
|
|
|
6 |
4 |
p. 1152-1161
|
article
|
| 3 |
Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia
|
Morimoto, Yuki
|
|
|
6 |
4 |
p. 1100-1114
|
article
|
| 4 |
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
|
Khorana, Alok A.
|
|
|
6 |
4 |
p. 1212-1221
|
article
|
| 5 |
Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission
|
Sukumar, Senthil
|
|
|
6 |
4 |
p. 1264-1270
|
article
|
| 6 |
Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
|
Lyski, Zoe L.
|
|
|
6 |
4 |
p. 1207-1211
|
article
|
| 7 |
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial
|
Rijneveld, Anita W.
|
|
|
6 |
4 |
p. 1115-1125
|
article
|
| 8 |
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study
|
Kwiatkowski, Janet L.
|
|
|
6 |
4 |
p. 1243-1254
|
article
|
| 9 |
Eculizumab for refractory thrombosis in antiphospholipid syndrome
|
Hussain, Habiba
|
|
|
6 |
4 |
p. 1271-1277
|
article
|
| 10 |
Editorial Board
|
|
|
|
6 |
4 |
p. i
|
article
|
| 11 |
Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study
|
Lissitchkov, Toshko
|
|
|
6 |
4 |
p. 1089-1094
|
article
|
| 12 |
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
|
Bataller, Alex
|
|
|
6 |
4 |
p. 1193-1206
|
article
|
| 13 |
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
|
Castellino, Alessia
|
|
|
6 |
4 |
p. 1350-1360
|
article
|
| 14 |
Gata2 +9.5 enhancer regulates adult hematopoietic stem cell self-renewal and T-cell development
|
You, Xiaona
|
|
|
6 |
4 |
p. 1095-1099
|
article
|
| 15 |
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
|
Delforge, Michel
|
|
|
6 |
4 |
p. 1309-1318
|
article
|
| 16 |
Is a BTKi or BCL2i preferable for first “novel” therapy in CLL? The case for BTKis
|
Brem, Elizabeth A.
|
|
|
6 |
4 |
p. 1361-1364
|
article
|
| 17 |
Is BTKi or BCL2i preferable as first novel therapy in patients with CLL? The case for BCL2i
|
Seymour, John F.
|
|
|
6 |
4 |
p. 1365-1370
|
article
|
| 18 |
Momelotinib is a highly potent inhibitor of FLT3-mutant AML
|
Azhar, Mohammad
|
|
|
6 |
4 |
p. 1186-1192
|
article
|
| 19 |
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
|
Gregory, Gareth P.
|
|
|
6 |
4 |
p. 1232-1242
|
article
|
| 20 |
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
|
Tam, Constantine S.
|
|
|
6 |
4 |
p. 1296-1308
|
article
|
| 21 |
Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States
|
Kuczmarski, Thomas M.
|
|
|
6 |
4 |
p. 1126-1136
|
article
|
| 22 |
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma
|
Voorhees, Timothy J.
|
|
|
6 |
4 |
p. 1255-1263
|
article
|
| 23 |
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis
|
Gagelmann, Nico
|
|
|
6 |
4 |
p. 1222-1231
|
article
|
| 24 |
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma
|
Nastoupil, Loretta J.
|
|
|
6 |
4 |
p. 1143-1151
|
article
|
| 25 |
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion–associated myeloid neoplasm
|
Miltiadous, Oriana
|
|
|
6 |
4 |
p. 1137-1142
|
article
|
| 26 |
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study
|
Mascarenhas, John
|
|
|
6 |
4 |
p. 1162-1174
|
article
|
| 27 |
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
|
Martínez-Cuadrón, David
|
|
|
6 |
4 |
p. 1278-1295
|
article
|
| 28 |
T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity
|
Lum, Su Han
|
|
|
6 |
4 |
p. 1319-1328
|
article
|
| 29 |
Unrelated donor α/β T cell– and B cell–depleted HSCT for the treatment of pediatric acute leukemia
|
Leahy, Allison Barz
|
|
|
6 |
4 |
p. 1175-1185
|
article
|
| 30 |
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001
|
Tran, Thai Hoa
|
|
|
6 |
4 |
p. 1329-1341
|
article
|
Journal description